scholarly journals A journey of gender in health: Transforming health by promoting gender considerations through comic art

2021 ◽  
Vol 00 (00) ◽  
pp. 1-18
Author(s):  
Phillip Joy ◽  
Alina Cosma ◽  
Samantha Goodliffe ◽  
Sarah Hiltner ◽  
Tessa Magnée ◽  
...  

Sex and gender are determinants of health outcomes across an individual’s life course. However, often in health research and practice, sex and gender considerations are either overlooked or confounded. Recent developments in health research and practice ask for the inclusion of sex and gender considerations within health research and practice. This article is a reaction to these calls. It explores the ways in which an international team of health researchers created a comic book that highlighted the impact of gender in many areas of health across an individual’s life course. The creative processes are critically explored, as well as selected images. Through this work, it is proposed that comic art knowledge mobilization projects can be viewed as means to transform health research and practice by critiquing and disrupting dominant cis-heteronormative sex and gender discourses.

2021 ◽  
Vol 22 (11) ◽  
pp. 5808
Author(s):  
Annalisa Giandalia ◽  
Alfio Edoardo Giuffrida ◽  
Guido Gembillo ◽  
Domenico Cucinotta ◽  
Giovanni Squadrito ◽  
...  

Diabetic kidney disease (DKD) is one of the most serious complications of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Current guidelines recommend a personalized approach in order to reduce the burden of DM and its complications. Recognizing sex and gender- differences in medicine is considered one of the first steps toward personalized medicine, but the gender issue in DM has been scarcely explored so far. Gender differences have been reported in the incidence and the prevalence of DKD, in its phenotypes and clinical manifestations, as well as in several risk factors, with a different impact in the two genders. Hormonal factors, especially estrogen loss, play a significant role in explaining these differences. Additionally, the impact of sex chromosomes as well as the influence of gene–sex interactions with several susceptibility genes for DKD have been investigated. In spite of the increasing evidence that sex and gender should be included in the evaluation of DKD, several open issues remain uncovered, including the potentially different effects of newly recommended drugs, such as SGLT2i and GLP1Ras. This narrative review explored current evidence on sex/gender differences in DKD, taking into account hormonal, genetic and clinical factors.


2014 ◽  
Vol 23 (11) ◽  
pp. 941-947 ◽  
Author(s):  
Saralyn Mark ◽  
Graham B.I. Scott ◽  
Dorit B. Donoviel ◽  
Lauren B. Leveton ◽  
Erin Mahoney ◽  
...  

2020 ◽  
Vol 61 (1) ◽  
pp. 109-119
Author(s):  
Lisanne Jeannine van Hagen ◽  
Maaike Muntinga ◽  
Yolande Appelman ◽  
Petra Verdonk

2020 ◽  
Vol 11 ◽  
Author(s):  
Irene Göttgens ◽  
Angelika D. van Halteren ◽  
Nienke M. de Vries ◽  
Marjan J. Meinders ◽  
Yoav Ben-Shlomo ◽  
...  

2020 ◽  
Vol 4 ◽  
pp. 247028972094187
Author(s):  
Jennifer L. Marsella ◽  
Katherine M. Sharkey

Over the past 3 decades, significant strides have been made in the field of sleep medicine for women. The impact of sex and gender on sleep health and sleep disorders received little attention in the early 1990s, but driven by policies ensuring inclusion of women in medical research, more recent studies have identified sex differences in sleep and investigated gender differences in sleep disorders. Nevertheless, disparities remain: diagnosis of sleep disorders, such as obstructive sleep apnea, narcolepsy, and rapid eye movement (REM) sleep behavior disorder are often delayed and underdiagnosed in women. Future research should continue to examine how biological sex and identity across the gender spectrum influence sleep health and sleep disorders, allowing for more personalized health care for all patients.


Author(s):  
Lorraine Greaves ◽  
Natalie Hemsing

Cannabis is the second most frequently used substance in the world and regulated or legalized for recreational use in Canada and fourteen US states and territories. As with all substances, a wide range of sex and gender related factors have an influence on how substances are consumed, their physical, mental and social impacts, and how men and women respond to treatment, health promotion, and policies. Given the widespread use of cannabis, and in the context of its increasing regulation, it is important to better understand the sex and gender related factors associated with recreational cannabis use in order to make more precise clinical, programming, and policy decisions. However, sex and gender related factors include a wide variety of processes, features and influences that are rarely fully considered in research. This article explores myriad features of both sex and gender as concepts, illustrates their impact on cannabis use, and focuses on the interactions of sex and gender that affect three main areas of public interest: the development of cannabis use dependence, the impact on various routes of administration (ROA), and the impact on impaired driving. We draw on two separate scoping reviews to examine available evidence in regard to these issues. These three examples are described and illustrate the need for more comprehensive and precise integration of sex and gender in substance use research, as well as serious consideration of the results of doing so, when addressing a major public health issue such as recreational cannabis use.


Sign in / Sign up

Export Citation Format

Share Document